Cargando…

Tumor cell plasticity and intrinsic immunogenicity: Implications for immunotherapy resistance in small‐cell lung cancer

Detalles Bibliográficos
Autor principal:	Ruan, Ji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487807/ https://www.ncbi.nlm.nih.gov/pubmed/34467633 http://dx.doi.org/10.1111/1759-7714.14117

Ejemplares similares

MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer
por: Ruan, Ji
Publicado: (2021)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

Effect of chromatin modifiers on the plasticity and immunogenicity of small-cell lung cancer
por: Kirk, Nicole A., et al.
Publicado: (2022)

Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer
por: Otegui, Nerea, et al.
Publicado: (2023)

Immunotherapy in non-small cell lung cancer: advancements and challenges
por: Zhou, Fei, et al.
Publicado: (2021)

M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance
por: Zheng, Naisheng, et al.
Publicado: (2023)

Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer
por: Kepp, Oliver, et al.
Publicado: (2020)

Integration of tumor extrinsic and intrinsic features associates with immunotherapy response in non-small cell lung cancer
por: Lau, Denise, et al.
Publicado: (2022)

Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade
por: Kroemer, Guido, et al.
Publicado: (2021)

Immunotherapy in non‐small cell lung cancer: The past, the present, and the future
por: Lu, Meng, et al.
Publicado: (2019)

Immunotherapy as a targeted therapy in non-small cell lung cancer
por: Rocco, Danilo, et al.
Publicado: (2019)

Mechanisms of Intrinsic Tumor Resistance to Immunotherapy
por: Rieth, John, et al.
Publicado: (2018)

Single-cell insights into the dynamic tumor microenvironment changes during immunotherapy of non-small cell lung cancer
por: Prazanowska, Karolina Hanna, et al.
Publicado: (2023)

Neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence
por: Cao, Christopher, et al.
Publicado: (2020)

Neoadjuvant immunotherapy in resectable non-small cell lung cancer at a checkpoint
por: Faltermeier, Claire M., et al.
Publicado: (2021)

Expert consensus on perioperative immunotherapy in non-small cell lung cancer: an editorial
por: Facchinetti, Francesco, et al.
Publicado: (2021)

Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy
por: Yao, Han, et al.
Publicado: (2018)

Tumor-intrinsic determinants of immunogenic cell death modalities
por: Workenhe, Samuel T, et al.
Publicado: (2021)

Plasticity of circulating tumor cells in small cell lung cancer
por: Seo, Jiyoun, et al.
Publicado: (2023)

Expert consensus on perioperative immunotherapy for locally advanced non-small cell lung cancer
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Characterization of the tumor microenvironment by single-cell RNA sequencing in non-small cell lung cancer treated with neo-adjuvant immunotherapy
por: Nagl, Laurenz, et al.
Publicado: (2023)

Efficacy of second-line chemotherapy after immunotherapy in advanced non-small cell lung cancer
por: Hirata, Tsuyoshi, et al.
Publicado: (2023)

Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy
por: Cuyàs, Elisabet, et al.
Publicado: (2020)

(−)-Guaiol triggers immunogenic cell death and inhibits tumor growth in non-small cell lung cancer
por: Yang, Xiaohui, et al.
Publicado: (2022)

Immunogenic cell death in cancer immunotherapy
por: Choi, Minji, et al.
Publicado: (2023)

T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells
por: Nouri, Yasmin, et al.
Publicado: (2021)

STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer
por: Attili, Ilaria, et al.
Publicado: (2018)

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
por: Adkins, Irena, et al.
Publicado: (2015)

EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment
por: Madeddu, Clelia, et al.
Publicado: (2022)

Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy
por: Coleman, Michael F., et al.
Publicado: (2020)

LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy
por: Egranov, Sergey D., et al.
Publicado: (2020)

Immunotherapy in Small Cell Lung Cancer
por: Esposito, Giovanna, et al.
Publicado: (2020)

Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity
por: Terry, Stéphane, et al.
Publicado: (2018)

N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy
por: Krug, Julia, et al.
Publicado: (2023)

EGFR and non-small cell lung cancer: implications for surgical practice
por: Varela, Gonzalo, et al.
Publicado: (2020)

Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
por: Liu, Guohao, et al.
Publicado: (2022)

Neoadjuvant immunotherapy with resectable non-small cell lung cancer: recent advances and future challenges
por: Ren, Sijia, et al.
Publicado: (2020)

Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail
por: Cali Daylan, Ayse Ece, et al.
Publicado: (2023)

Taking it up a notch: a promising immunotherapy against small cell lung cancer
por: Apaydin, Alanisse A., et al.
Publicado: (2023)

Resisting resistance to cancer immunotherapy
por: Lam, Walter Sze‐Tung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l25e2t4cbh236v5vfecu24mm4n